Brief: Sprint Bioscience Regains Rights To Nash Program
May 30 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* REGAINS RIGHTS TO NASH PROGRAM
* LICENSE PARTNER LG CHEM HAS ANNOUNCED THAT THEY DO NOT
INTENDS
TO CONTINUE THE NASH PROGRAM
* IMMEDIATELY BEGINS THE WORK OF FINDING A NEW PARTNER FOR
THE
PROGRAM
Source text for Eikon: ID:nMFN4j7yWM
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln